The companies completed the merger earlier this month after working as partner firms since 2020. Both companies are focused on the development and production of bone-graft products.
Since 2020, the companies have worked together on the development of Isto’s SPARC integrative bone matrix, which stemmed from Advanced Biologics’ OsseoGen tissue processing method.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.